InVivo Therapeutics, which specializes in spinal cord injuries, names Richard Toselli, M.D., as its president and chief executive.

Boston Scientific released its full-year earnings forecast that fell below Wall Street expectations as the company reiterated its plans to make several more…

Qiagen will gain control of a pipeline of assay panels designed to diagnose infections affecting the respiratory and gastrointestinal systems.

The agreement with IBM clears Elekta to start offering the artificial intelligence technology alongside its oncology information system.

Med-Ally, the maker of active medical devices like the VersaStim neuromodulation platform, said it is moving its operations to Goose Creek in Berkeley County,…

The agreement sees Boston Scientific buy $90 million of Millipede stock and gain the right to acquire the rest of the business for up to $450 million.

J&J began assessing whether to sell subsidiaries that make glucose meters, insulin pumps and other pieces of diabetes equipment last year.

The alliance will see Foundation Medicine use pan-cancer test FoundationOne CDx as a companion diagnostic for Pfizer drugs.

The initiative will provide certain UnitedHealth members with Dexcom’s CGM technology and personalized coaching to help manage their diabetes.